U.S. SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 |_| Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). ================================================================================ 1. Name and Address of Reporting Person* Commonwealth Associates, L.P. -------------------------------------------------------------------------------- (Last) (First) (Middle) 830 Third Avenue -------------------------------------------------------------------------------- (Street) New York New York 10022 -------------------------------------------------------------------------------- (City) (State) (Zip) ================================================================================ 2. Issuer Name and Ticker or Trading Symbol drkoop.com, Inc. (NASD OTCBB: KOOP) ================================================================================ 3. IRS Identification Number of Reporting Person, if an Entity (Voluntary) ================================================================================ 4. Statement for Month/Year August 2001 ================================================================================ 5. If Amendment, Date of Original (Month/Year) ================================================================================ 6. Relationship of Reporting Person to Issuer (Check all applicable) |X| Director |X| 10% Owner |_| Officer (give title below) |_| Other (specify below) ================================================================================ 7. Individual or Joint/Group Filing (Check Applicable Line) |_| Form filed by one Reporting Person |X| Form filed by more than one Reporting Person ================================================================================ * If the Form is filed by more than one Reporting Person, see Instruction 4(b)(v). ================================================================================ Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned ================================================================================

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. Page 1 of 2 FORM 4 (continued) Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) ================================================================================

Explanation of Responses: See attached footnotes. ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Commonwealth Associates, L.P. By: Commonwealth Associates Management Company, Inc. /s/ Joseph Wynne September 7, 2001 --------------------------------------------- ----------------------- ** Signature of Reporting Person Date Joseph Wynne Chief Financial Officer Note: File three copies of this Form, one of which must be manually signed. If space provided is insufficient, see Instruction 6 for procedure. FOOTNOTES Page 3 of 4 (1) These are warrants to purchase shares of Series E 8% Convertible Preferred Stock ("Preferred Stock;" each such share being convertible into 125 shares of Common Stock) at an exercise price of $10.00 per share. The warrants were issued to Commonwealth Associates, L.P. ("Commonwealth") by drkoop.com, Inc. (the "Company") in consideration of services performed by Commonwealth in connection with a private placement of Preferred Stock which closed in August 2001 (the "Private Placement"). (2) These securities are owned directly by Commonwealth, the general partner of which is Commonwealth Associates Management Company, Inc. ("CAMC"). Michael S. Falk ("Falk") and Robert Priddy ("Priddy") are directors and shareholders of CAMC. Falk is the Chairman and principal shareholder of CAMC, which is the principal partner of Commonwealth. Falk and Priddy disclaim beneficial ownership of the securities held by Commonwealth other than that portion which corresponds with their respective interests in Commonwealth. (3) The 36,853,692 shares identified are beneficially owned by Falk, and include (i) 7,908,547 shares of derivative securities owned by Commonwealth, (ii) 26,883,924 shares of derivative securities owned by ComVest Venture Partners, LP (see note 5 below), and (iii) 2,074,826 shares of derivative securities owned directly Falk. Falk disclaims beneficial ownership of the securities held by ComVest Venture Partners, LP other than that portion which corresponds with his interests in such entity. (4) These shares of Preferred Stock were purchased by Priddy in the Private Placement at a purchase price of $10.00 per share (for an aggregate purchase price of $1,135,000). The 19,901,786 shares identified as beneficially owned on this line consists of the 14,187,000 shares purchased by Priddy in the Private Placement, and an additional 5,714,286 of derivative securities owned directly by RMC Capital, LLC ("RMC"). Priddy is a manager and the principal of RMC and disclaims beneficial ownership of the securities held by RMC other than that portion which corresponds with his membership interest therein. (5) These shares of Preferred Stock were purchased by ComVest Venture Partners, LP in the Private Placement at a purchase price of $10.00 per share (for an aggregate purchase price of $625,000). ComVest Management, LLC, which is wholly-owned by CAMC, is the general partner of ComVest Venture Partners, LP. Page 4 of 4 JOINT FILER INFORMATION AND AUTHORIZATION Name: Commonwealth Associates Management Company, Inc. 830 Third Avenue New York, New York 10022 Designated Filer: Commonwealth Associates, LP Issuer & Ticker Symbol: drkoop.com, Inc. (KOOP) Statement Month/Year: August 2001 Signature: /s/ Joseph Wynne ------------------------------------------------------- Joseph Wynne, Chief Financial Officer Name: ComVest Venture Partners, LP 830 Third Avenue New York, New York 10022 Designated Filer: Commonwealth Associates, L.P. Issuer & Ticker Symbol: drkoop.com, Inc. (KOOP) Statement Month/Year: August 2001 Signature: /s/ Michael S. Falk ------------------------------------------------------- Michael S. Falk, Manager of General Partner Name: ComVest Management, LLC 830 Third Avenue New York, New York 10022 Designated Filer: Commonwealth Associates, L.P. Issuer & Ticker Symbol: drkoop.com, Inc. (KOOP) Statement Month/Year: August 2001 Signature: /s/ Michael S. Falk ------------------------------------------------------- Michael S. Falk, Manager Name: Michael S. Falk 830 Third Avenue New York, New York 10022 Designated Filer: Commonwealth Associates, L.P. Issuer & Ticker Symbol: drkoop.com, Inc. (KOOP) Statement Month/Year: August 2001 Signature: /s/ Michael S. Falk ------------------------------------------------------- Michael S. Falk Name: Robert Priddy 1640 Powers Ferry, Suite 125 Marietta, Georgia 30067 Designated Filer: Commonwealth Associates, L.P. Issuer & Ticker Symbol: drkoop.com, Inc. (KOOP) Statement Month/Year: August 2001 Signature: /s/ Robert Priddy ------------------------------------------------------- Robert Priddy

COMMONWEALTH ASSOCIATES LP 4